Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Innovent Announced 2021 Annual Results 2022-03-30 08:00
Everest Medicines Announces that Licensing Partner Pfizer Reports Positive Topline Results from Yearlong Phase 3 Trial of Etrasimod in Ulcerative Colitis Patients, Underscoring Best-in-Class Potential 2022-03-30 08:00
Telix Granted FDA Orphan Drug Designation for Bone Marrow Conditioning Treatment 2022-03-29 13:34
Daewoong Pharmaceutical submitted NDA for its global new drug Fexuclue Tablets to the Philippines 2022-03-29 09:00
Innovent Announces First Patient Dosing of Claudin18.2/CD3 Bispecific Antibody IBI389 in Phase 1a/1b Clinical Trial for Advanced Solid Tumor 2022-03-29 08:10
Telix and Xiel Sign U.K. and Ireland Distribution Agreement for Illuccix® 2022-03-29 07:39
Everest Medicines Announces Financial Results for Full Year Ended December 31, 2021 2022-03-29 06:30
ILC Dover Announces Liquid Single-Use Bioprocessing Bags for Rapidly Growing Biotherapeutics and Cell & Gene Therapy Markets 2022-03-29 05:11
Viva Biotech Announced 2021 Annual Results: Revenue Increased by 201.9% YoY, CRO Business Revenue Maintained Rapid Growth with an Increase of 68.7% 2022-03-29 01:01
Biocytogen Expands Global Footprint with the Opening of Biocytogen Europe Innovation Center in Germany 2022-03-28 21:30
Vela Diagnostics Launches Focused (60 Genes) and Comprehensive (525 Genes) NGS-Based Pan-Cancer Panels 2022-03-28 15:00
AXA offers free additional 'Cleaning and Sanitising Benefit' to home contents insurance and SME customers 2022-03-28 13:28
Hyperflex® Balloon Catheter by Endovastec™ Receives Marketing Approval in Japan 2022-03-28 12:29
miR Scientific and Leonie Hill Capital Announce Collaboration to Introduce Breakthrough Urine Liquid Biopsy Prostate Cancer Test in Singapore 2022-03-28 09:09
Free Guide to Colorectal Cancer Screening from NCCN Now Available in More Than a Dozen Languages 2022-03-28 09:07
Innovent and Lilly Expand Strategic Partnership in Oncology 2022-03-28 08:00
Ascletis Announces the Latest Results of the Preclinical Studies of Two Novel Anti-Cancer Drug Candidates, ASC61 and ASC60, to be presented at AACR Annual Meeting 2022 2022-03-27 18:30
Saudi Arabia reopens visa on arrival for US, UK and Schengen visa holders 2022-03-25 21:58
Henlius Receives NMPA Approval for its First Innovative Monoclonal Antibody HANSIZHUANG 2022-03-25 21:24
Abcam the most awarded company at 2022 industry awards 2022-03-25 20:40
1 220 221 222 223 224 741